Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2005-04-05
2005-04-05
Qazi, Sabiha (Department: 1616)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C514S167000, C514S170000, C514S171000, C514S172000
Reexamination Certificate
active
06875758
ABSTRACT:
The invention provides a method of using pregnadienones and pregnadienols represented by the structural formula (I) as shown herein belowWherein X═OH or O or combination thereof and positioning of olefinic bonds are at 4(5); 5(6); 16(17); 17(20) or various combinations and said compounds containing at least one olefinic bond in or on their D-ring for the treatment of hyperlipidemic and hyperglycemic conditions in mammals, said method comprising administering an effective amount of the said compounds to the recipient mammals.
REFERENCES:
patent: 0 562 849 (1993-09-01), None
Arya, V., “Gugulipid,”Drugs of the Future, 13(7):618-619 (1988).
Collins, D., “Sex hormone receptor binding, progestin selectivity, and the new oral contraceptives,”American Journal of Obstetrics and Gynecology, 170(5)2:1508-1513 (1994).
London, R., “The New Era in Oral Contraception: Pills Containing Gestodene, Norgestimate, and Desogestrel,”Obstetrical and Gynecological Survey, 47(11):777-782 (1992).
Townsley, “Further Studies on the Regulation of Human Placental Steroid 3-Sulfatase Activity,”Endocrinology, 93(1): 172-181 (1973).
Ahmed-Sorour et al., “Role of Ovarian Hormones in the Long-Term Control of Glucose Homeostasis,”Hormone Research, 13(6):396-403 (1980).
Ghaleb et al., “Interaction of Progesterone with Insulin and Tolbutamide in Normal and Alloxan Diabetic Rats,” Journal ofDrug Research Egypt, 5(2):13-21 (1973).
Sutter-Dub et al., “Progesterone and Insulin-Resistance in the Pregnant Rat,”Diabete & Metabolisme (Paris), 7(2):97-104 (1981).
Anand Nitya
Asthana Omkar Prasad
Chander Ramesh
Dev Sukh
Ghatak Ashim
Council of Scientific & Industrial Research
Qazi Sabiha
LandOfFree
Method of treating hyperlipidemic and hyperglycemic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating hyperlipidemic and hyperglycemic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating hyperlipidemic and hyperglycemic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3427136